One Nucleus - BioWednesday Webinar: Opportunities for UK Life Sciences - A US Perspective

  • Wednesday, 5 May 2021, 4:00 PM to 5:30 PM

The past year has seen record investment and deal levels across the Life Sciences sector. Far from stifling investment the pandemic has seemingly turbocharged the system and not just for those actively involved in Covid-19. The UK Life Science innovation field has demonstrated its strengths with R&D, both with successful clinical studies on treatments, surveillance and diagnostics of Covid-19 variants but in non-related areas such as immune-oncology. This has not gone unnoticed by investors with the UK Life Sciences sector seeing a record breaking year of venture investment, successful IPOs and significant M&A deals. With deal values high in the US and the UK demonstrating its value, the panel will discuss what this means for the UK businesses seeking investment, licensing deals and alliances in the US.


  • Mike Ward, Global Head of Thought Leadership, Clarivate
  • Chris Loryman, Senior Manager, UC San Diego Office of Innovation and Commercialization
  • Chad Shear, Principal, Fish & Richardson
  • Cathy Tralau-Stewart, Senior Director Alliances, Takeda and Visiting Scholar at Stanford
  • Jason Mellad, CEO & Co-Founder, Start Codon

One Nucleus Members: Free
Non-Members: £50 +VAT

In association with Fish & Richardson

Find out more from One Nucleus

Stevenage Bioscience Catalyst is the UK's leading open innovation campus with a focus on therapeutics.

Learn more

We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.